Are we overestimating left ventricular abnormalities in end-stage renal disease?

Liermann D, Zidek W. Prevention of radiographiccontrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180–184 17. Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a metaanalysis of 13 randomized trials. Am Heart J 2006; 151: 140–145 18. Briguori C, Columbo A, Violante A et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004; 25: 206–211 19. Spargias I, Alexopoulos E, Kyrzopoulos S et al. Ascorbic acid prevents contrast-mediated nephropathy in patient with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837–2842 20. Teirstein P, Price MJ, Mathus V et al. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization. Am J Cardiol 2006; 97: 1076–1081 21. Nyman U, Almen T, Aspelin R, Hellstrom M, Kristiansson M, Sterner G. Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 2005; 46: 830–842 22. Barrett B, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of highand low-osmolality iodinated contrast media. Radiology 1993; 188: 171–178 23. Aspelin P, Aubry P, Fransson S, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491–499 24. Barrett B, Thomsen H, Katzberg R. Nephrotoxicity of lowosmolar iopamidol vs iso-osmolar iodixanol in renally impaired patients: the IMPACT study. Invest Radiol 2006; 41: 815–821 25. Jo S, Youn TJ, Koo BW et al. Renal toxicity evaluation and comparison between visipaque (Iodixanol) and hexabrix (Ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. JACC 2006; 48: 924–930 26. Hardiek K, Katholi RE, Robbs RS, Katholi CE. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diab Compl 2007 (Accepted for publication) 27. Solomon R, Natarajan MK, Doucet S et al. The CARE (Cardiac Angiography in REnally Imparied Patients) Study: a randomized, double-blind trial of contrast-induced nephropathy in high risk patients. Circulation 2007; 115 (Accepted for publication) 28. Tepel M, Aspelin P, OLameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006; 113: 1799–1806 29. Berger E, Bader BD, Bosker J, Risler T, Erley CM. Renal failure induced by contrast medium injection cannot be prevented by haemodialysis. Dtsch med Wschr 2001; 126: 162–166 30. Frank H, Werner D, Lorusso V et al. Simultaneous hemodialysis during coronary angiography fails to prev ent radiocontrastinduced nephropathy in chronic renal failure. Clin Nephrol 2003; 60: 176–182 31. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P. Effect of hemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 1998; 13: 358–362 32. Vogt B, Ferrari P, Schonholzer C et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692–698 33. Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333–1340 34. Marenzi G, Lauri G, Campodonico J et al. Comparison of two hemofiltration protocols for prevention of contrastinduced nephropathy in high-risk patients. Am J Med 2006; 119: 155–162